Cutaneous infections due to Acanthamoeba in patients with acquired immunodeficiency syndrome

Archives of Internal Medicine

Volumn 157, Issue 5, 1997, Pages 569-572

  Chandrasekar, Pranatharthi H ^a,b   Nandi, Partha S ^b   Fairfax, Marilyn R ^b   Crane, Lawrence R ^a,b  

^a Division of Pediatric Infectious Diseases   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CHLORHEXIDINE GLUCONATE; FLUCONAZOLE; KETOCONAZOLE; PENTAMIDINE;

ACANTHAMOEBA; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN INFECTION; SUBCUTANEOUS NODULE;

EID: 0031046932     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.5.569     Document Type: Article

References (18)

1. Sison JP, Kemper CA, Loveless M, McShane D, Visvesvara GS, Deresinksi SC. Disseminated Acanthamoeba infection in patients with AIDS: case reports and review. Clin Infect Dis. 1195;20:1207-1216.
2. Visvesvara GS, Stenr-Green JK. Epidemiology of free-living ameba infections. J Protozool. 1990 (suppl);37:25S-33S.
3. Wiley CA, Safrin RE, Davis CE, et al. Acanthamoeba meningoencephalitis in a patient with AIDS. J Infect Dis. 1987;155:130-133.
4. Anzil AP, Rao C, Wrzolek MA, Visvesvara GS, Sher JH, Kozlowski PB. Amebic meningoencephalitis in a patient with AIDS caused by a newly recognized opportunistic pathogen. Arch Pathol Lab Med. 1991;115:21-25.
5. Gonzalez MM, Gould E, Dickinson G, et al. Acquired immunodeficiency syndrome associated with Acanthamoeba infection and other opportunistic organisms. Arch Pathol Lab Med. 1986;110:749-751.
6. Martinez AJ, Dos Santos Neto JG, Nelson EC, Stamm WP, Willaert E, Primary amebic meningoencephalitis, Pathol Annu. 1977;12:225-250.
7. de Jonckheere JF. Ecology of Acanthamoeba. Rev Infect Dis. 1991;13(suppl 5):S385-S387.
8. Martinez AJ. Is Acanthamoeba encephalitis an opportunistic infection? Neurology. 1980;30:567-574.
9. Wang SS, Feldman HA. Isolation of Hartmannella species from human throats. N Engl J Med. 1967;227:1174-1179.
10. Martinez AJ. Infection of the central nervous system due to Acanthamoeba. Rev infect Dis. 1991;13(suppl 5):S399-S402.
11. Stehr-Green JK, Bailey TM, Visvesvara GS. The epidemiology of Acanthamoeba keratitis In the United States. Am J Ophthalmol. 1989;107:331-336
12. Helton J, Loveless M, White CR. Cutaneous Acanthamoeba infection associated with leukocytoclastic vasculitis in an AIDS patient. Am J Dermatopathol. 1993;15:146-149.
13. Duma RJ, Finley R, In vitro susceptibility of pathogenic Naegleria and Acanthamoeba species to a variety of therapeutic agents. Antimicrob Agents Chemother. 1976;10:370-376.
14. Slater CA, Sickel JZ, Visvesvara GS, Pabico RC, Gaspari AA, Successful treatment of disseminated Acanthamoeba infection in an immunocompromised patient. N Engl J Med. 1994;331:85-87.
15. Osata MS, Robinson, NM, Wilhelmus KR, Jones DB. In vitro evaluation of antimicrobial compounds for cysticidal activity against Acanthamoeba. Rev Infect Dis. 1991;13(suppl 5):S431-S435.
16. Das SR, Asiri S, El-Soofi A, Baer HP. Protective and curative effects of rifampin in Acanthamoeba meningitis of the mouse. J Infect Dis. 1991;163:916-917.
17. Culbertson CG, Holmes DH, Overton WM. Hartmannella castellanii (Acanthamoeba sp.): preliminary report on experimental chemotherapy. Am J Clin Pathol. 1965;43:361-364.
18. Stevens AR, O'Dell WD, In vitro and in vivo activity of 5-fluorocytosine on Acanthamoeba. Antimicrob Agents Chemother. 1974;6:282-289.